MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER)
https://doi.org/10.20996/1819-6446-2013-9-2-133-137
Abstract
Aim. To assess the quality of lipid-lowering therapy in high risk patients with cardiovascular diseases during medical supervision in specialized center.
Material and methods. The data of the PROFIL register are used. All patients having cardiovascular diseases, high cardiovascular risk, and seeking medical attention in specialized medical center were enrolled into this register. Patients (n=274) were split into groups: control group (n=82, patients who have applied for the first time for medical care), the main subgroup A (n=167; patients observed last 2 years), and the main subgroup B (n=25; patients observed more than 2 years).
Results. The total cholesterol blood level was significantly lower in the main group compared to the control (p<0.05). Statins were constantly taken by 34% of patients in the control group, 71.6% - in subgroup A, and 61% - in subgroup B (p<0.05).
Conclusion. Medical supervision in specialized medical center leads to better blood lipid control and patient compliance to statin therapy.
About the Authors
S. Yu. Martsevich
State Research Centre for Preventive Medicine, Moscow;
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
O. V. Gaysenok
State Research Centre for Preventive Medicine, Moscow;
Joint Hospital and Polyclinic, Department of Affairs of the President of the Russian Federation
Russian Federation
Russian Federation
S. G. Tripkosh
State Research Centre for Preventive Medicine, Moscow
Russian Federation
Russian Federation
A. V. Zagrebelnyy
State Research Centre for Preventive Medicine, Moscow
Russian Federation
Russian Federation
Yu. V. Lukina
State Research Centre for Preventive Medicine, Moscow
Russian Federation
Russian Federation
References
1. Sever P.S., Dahlof B., Poulter N.R. et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomized controlled trial. Lancet 2003; 361: 1149–1158.
2. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360(9326):7–22.
3. Downs JR, Clearfield M, Weis S, et al. for the AFCAPS/TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA 1998; 279:1615–1622.
4. ESC/EAS Guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32: 1769–1818
5. Susekov A., M. Zubarev, Deev AD etc. The main results of the Moscow study on statins (Moscow Statin Survey, MSS). Serdtse 2006; 5 (6) :324–8 (Сусеков А.В., Зубарева М.Ю., Деев А.Д. и др. Основ- ные результаты Московского Исследования по Статинам (Moscow Statin Survey, MSS). Сердце 2006;5(6):324–8).
6. Yusuf S, Islam S, Chow CK, et al. Prospective Urban Rural Epidemiology (PURE) Study Investigators. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middleincome, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet 2011;378(9798):1231–43.
7. Lee HY, Cooke CE, Robertson TA. Use of Secondary Prevention Drug Therapy in Patients With Acute Coronary Syndrome After Hospital Discharge. J Manag Care Pharm 2008;14(3):271–80.
8. Ambardekar AV, Fonarow GC, Dai D, et al. Get With The Guidelines Steering Committee and Hospitals. Quality of care and in-hospital outcomes in patients with coronary heart disease in rural and urban hospitals (from Get With the Guidelines-Coronary Artery Disease Program). Am J Cardiol 2010;105(2):139–43.
9. Yarzebski J, Bujor CF, Goldberg RJ, et al. A community-wide survey of physician practices and attitudes toward cholesterol management in patients with recent acute myocardial infarction. Arch Intern Med 2002;162:797–804.
10. Martsevich SY, Drozdova LY, Lukina YV, et al. How to evaluate the possibility of practitioners of modern medical therapy in patients with chronic ischemic heart disease. Results of polls in Moscow and Voronezh. Rational Pharmacother Card 2010, 6 (2): 145–148. Russian (Марцевич С.Ю., Дроздова Л.Ю., Лукина Ю.В., и др. Как оценивают практические врачи возможности современной ме- дикаментозной терапии больных хронической ишемической болезнью сердца. Результаты опросов в Москве и Воронеже. РФК 2010; 6(2): 145–148).
11. Drozdova LY, Martsevich SY, Voronina VP. Simultaneous assessment of the prevalence and effectiveness of management of risk factors for cardiovascular disease among physicians and their knowledge of current clinical practice guidelines. The results of the project “Health and medical education”. Rational Pharmacother Card 2011, 7 (2) :137–144Russian (Дроздова Л.Ю., Марцевич С.Ю., Воронина В.П. Одновременная оценка распространенности и эффективности коррекции факторов риска сердечно-сосудистых заболеваний среди врачей и их знания современных клинических рекомендаций. Результаты проекта ≪Здоровье и образование врача≫. РФК 2011;7(2):137–144).
12. Eagle KA, Montoye CK, Riba AL, et al. Guideline-Based Standardized Care Is Associated With Substantially Lower Mortality in Medicare Patients With Acute Myocardial Infarction: The American College of Cardiology’s Guidelines Applied in Practice (GAP) Projects in Michigan. J Am Coll Cardiol 2005;46;1242–1248.
13. LaBresh KA, Fonarow GC, Smith SC Jr, et al. Get With The Guidelines Steering Committee. Improved treatment of hospitalized coronary artery disease patients with the get with the guidelines program. Crit Pathw Cardiol 2007;6:98–105.
14. Newby LK, LaPointe NM, Chen AY, et al. Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease. Circulation 2006;113:203–212.
15. Lewis WR, Ellrodt AG, Peterson E, et al. Trends in the Use of Evidence-Based Treatments for Coronary Artery Disease Among Women and the Elderly: Findings From the Get With the Guidelines Quality- Improvement Program. Circ Cardiovasc Qual Outcomes 2009;2;633–641.
Review
For citations:
Martsevich S.Yu., Gaysenok O.V., Tripkosh S.G., Zagrebelnyy A.V., Lukina Yu.V. MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER). Rational Pharmacotherapy in Cardiology. 2013;9(2):133-137. (In Russ.) https://doi.org/10.20996/1819-6446-2013-9-2-133-137
Views:
786
.jpg)
Email this article 